Vascepa is a prescription medication that is used to reduce the risk of cardiovascular events in adults with elevated triglyceride levels. The drug is manufactured by Amarin Pharma Inc. and is eligible for a discount through the Vascepa Co-pay Savings Program [2].

To be eligible for the Vascepa Co-pay Savings Program, patients must have commercial insurance coverage for Vascepa and must not be enrolled in any state or federally funded programs, such as Medicare, Medicaid, or VA [2]. Patients who meet these criteria may be able to pay as little as $9 per month for their Vascepa prescription [2].

It is important to note that the Vascepa Co-pay Savings Program is not available to patients who are uninsured or who have insurance coverage through a government-funded program [2]. Additionally, the program is only available to patients who are prescribed Vascepa for an FDA-approved indication [2].

In summary, to be eligible for the Vascepa Co-pay Savings Program, patients must have commercial insurance coverage for Vascepa, must not be enrolled in any state or federally funded programs, and must be prescribed Vascepa for an FDA-approved indication [2].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://vascepa.copaysavingsprogram.com/
[3] https://www.vascepa.com/